Missed NVDA?
Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
NVST Stock Forecast 2026-2027
$27.85
Current Price
$4.46B
Market Cap
Buy 7
Hold 8
Sell 0
Wall St Analyst Ratings
Distance to NVST Price Targets
+25.7%
To High Target of $35.00
+4.1%
To Median Target of $29.00
-31.8%
To Low Target of $19.00
NVST Price Momentum
+3.0%
1 Week Change
+11.9%
1 Month Change
+83.6%
1 Year Change
+28.3%
Year-to-Date Change
-8.4%
From 52W High of $30.42
+89.2%
From 52W Low of $14.72
📊 TOP ANALYST CALLS
Did NVST Make This Month's Elite Buy List?
We don't follow just any analyst — only the top 3% with a proven track record make our cut. See if Envista is one of their latest high-conviction picks.
Latest NVST Stock Price Targets & Analyst Predictions
Based on our analysis of 22 Wall Street analysts, NVST has a neutral consensus with a median price target of $29.00 (ranging from $19.00 to $35.00). The overall analyst rating is Buy (7.7/10). Currently trading at $27.85, the median forecast implies a 4.1% upside. This outlook is supported by 7 Buy, 8 Hold, and 0 Sell ratings.
Conversely, the most conservative target is provided by Jason Bednar at Piper Sandler, suggesting a 31.8% downside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
NVST Analyst Ratings
7
Buy
8
Hold
0
Sell
NVST Price Target Range
Low
$19.00
Average
$29.00
High
$35.00
Current: $27.85
Latest NVST Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for NVST.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Apr 15, 2026 | Citigroup | Daniel Grosslight | Neutral | Initiates | $29.00 |
| Apr 8, 2026 | Evercore ISI Group | Elizabeth Anderson | Outperform | Maintains | $30.00 |
| Feb 11, 2026 | Barclays | Glen Santangelo | Overweight | Maintains | $34.00 |
| Feb 10, 2026 | Mizuho | Steven Valiquette | Neutral | Maintains | $27.00 |
| Feb 6, 2026 | Piper Sandler | Jason Bednar | Neutral | Reiterates | $25.00 |
| Feb 6, 2026 | Stifel | Jonathan Bock | Buy | Maintains | $31.00 |
| Feb 6, 2026 | JP Morgan | Lilia-Celine Lozada | Neutral | Maintains | $26.00 |
| Feb 6, 2026 | Wells Fargo | Vik Chopra | Equal-Weight | Maintains | $26.00 |
| Feb 4, 2026 | Stifel | Jonathan Bock | Buy | Maintains | $27.00 |
| Feb 3, 2026 | UBS | Kevin Caliendo | Neutral | Maintains | $25.00 |
| Jan 30, 2026 | Piper Sandler | Jason Bednar | Neutral | Maintains | $21.00 |
| Jan 20, 2026 | Mizuho | Steven Valiquette | Neutral | Upgrade | $24.00 |
| Dec 16, 2025 | JP Morgan | Lilia-Celine Lozada | Neutral | Maintains | $22.00 |
| Dec 9, 2025 | Barclays | Glen Santangelo | Overweight | Initiates | $24.00 |
| Aug 1, 2025 | Piper Sandler | Jason Bednar | Neutral | Maintains | $19.00 |
| Aug 1, 2025 | Morgan Stanley | Erin Wright | Equal-Weight | Maintains | $17.00 |
| Aug 1, 2025 | Stifel | Jonathan Bock | Buy | Maintains | $25.00 |
| Aug 1, 2025 | Mizuho | Steven Valiquette | Underperform | Maintains | $18.00 |
| Aug 1, 2025 | Wells Fargo | Vik Chopra | Equal-Weight | Maintains | $19.00 |
| Jul 29, 2025 | UBS | Kevin Caliendo | Neutral | Maintains | $22.00 |
Envista Holdings Corporation (NVST) Competitors
The following stocks are similar to Envista based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Envista Holdings Corporation (NVST) Financial Data
Envista Holdings Corporation has a market capitalization of $4.46B with a P/E ratio of 99.4x. The company generates $2.72B in trailing twelve-month revenue with a 1.7% profit margin.
Revenue growth is +15.0% quarter-over-quarter, while maintaining an operating margin of +10.7% and return on equity of +1.6%.
Valuation Metrics
Market Cap
$4.46B
Enterprise Value
$4.95B
P/E Ratio
99.4x
PEG Ratio
0.1x
Price/Sales
1.7x
Growth & Margins
Revenue Growth (YoY)
+15.0%
Gross Margin
+54.7%
Operating Margin
+10.7%
Net Margin
+1.7%
EPS Growth
+2,641.7%
Financial Health
Cash/Price Ratio
+26.5%
Current Ratio
2.4x
Debt/Equity
51.4x
ROE
+1.6%
ROA
+2.8%
💡 SKIP THE NOISE
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings — tracked and updated every Monday and Thursday.
Envista Holdings Corporation (NVST) Business Model
About Envista Holdings Corporation
What They Do
Develops and markets dental equipment and technology.
Business Model
The company generates revenue by developing, manufacturing, and selling a wide range of dental products and solutions to dental professionals. Its offerings include dental consumables, orthodontic appliances, and imaging equipment, which are essential for dental practices and laboratories.
Additional Information
Envista Holdings Corporation focuses on enhancing dental care quality through cutting-edge technology and promotes digital dentistry. The company is committed to research and development, continuously advancing the dental market to improve patient outcomes and efficiency. As a leader in the industry, Envista plays a significant role in setting benchmarks for innovation and technology integration in healthcare.
Company Information
Sector
Healthcare
Industry
Medical Instruments & Supplies
Employees
12,300
CEO
Mr. Paul A. Keel
Country
United States
IPO Year
N/A
Website
envistaco.comEnvista Holdings Corporation (NVST) Latest News & Analysis
Latest News
Quick Summary
Envista Holdings Corporation (NYSE: NVST) will release its Q1 2026 financial results on May 6, 2026.
Why It Matters
Envista's upcoming Q1 2026 financial results may impact investor sentiment, affecting stock price and market perception of the company's performance and growth outlook.
Source: PRNewsWire
Market Sentiment:
Neutral
Quick Summary
Zacks Style Scores help investors identify top-rated stocks tailored to their investing style, providing a useful tool for stock selection.
Why It Matters
Zacks Style Scores can help identify high-potential stocks aligned with specific investing strategies, enhancing portfolio performance and risk management.
Source: Zacks Investment Research
Market Sentiment:
Positive
Quick Summary
Envista (NVST) shares rose 42.5% in the past year, outperforming the industry, which declined by 22.5%, and the S&P 500, which gained 16.6%.
Why It Matters
Envista NVST's 42.5% share increase highlights strong performance against a declining industry and broader market, indicating robust demand and potential for future growth.
Source: Zacks Investment Research
Market Sentiment:
Positive
Quick Summary
Envista Holdings Corporation (NVST) is set for strong growth, supported by strategic priorities and favorable long-term trends in the dental industry.
Why It Matters
Envista's strategic positioning and favorable industry trends signal potential revenue growth, indicating a promising investment opportunity in the dental sector.
Source: Zacks Investment Research
Market Sentiment:
Positive
Quick Summary
Investors in Medical - Products stocks are evaluating the value of Envista (NVST) versus Stryker (SYK) for potential investment opportunities.
Why It Matters
The comparison of Envista and Stryker highlights potential value opportunities in the Medical - Products sector, influencing investment decisions and portfolio strategies.
Source: Zacks Investment Research
Market Sentiment:
Positive
Best Value Stocks to Buy for March 16th
1 month ago
Quick Summary
OPRX, NVST, and STRT were added to the Zacks Rank #1 (Strong Buy) list of value stocks on March 16, 2026.
Why It Matters
OPRX, NVST, and STRT being highlighted as Zacks Rank #1 (Strong Buy) suggests strong potential for growth, indicating favorable investment opportunities in the market.
Source: Zacks Investment Research
Market Sentiment:
Positive
Frequently Asked Questions About NVST Stock
What is Envista Holdings Corporation's (NVST) stock forecast for 2026?
Based on our analysis of 22 Wall Street analysts, Envista Holdings Corporation (NVST) has a median price target of $29.00. The highest price target is $35.00 and the lowest is $19.00.
Is NVST stock a good investment in 2026?
According to current analyst ratings, NVST has 7 Buy ratings, 8 Hold ratings, and 0 Sell ratings. The stock is currently trading at $27.85. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for NVST stock?
Wall Street analysts predict NVST stock could reach $29.00 in the next 12 months. This represents a 4.1% increase from the current price of $27.85. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Envista Holdings Corporation's business model?
The company generates revenue by developing, manufacturing, and selling a wide range of dental products and solutions to dental professionals. Its offerings include dental consumables, orthodontic appliances, and imaging equipment, which are essential for dental practices and laboratories.
What is the highest forecasted price for NVST Envista Holdings Corporation?
The highest price target for NVST is $35.00 from at , which represents a 25.7% increase from the current price of $27.85.
What is the lowest forecasted price for NVST Envista Holdings Corporation?
The lowest price target for NVST is $19.00 from Jason Bednar at Piper Sandler, which represents a -31.8% decrease from the current price of $27.85.
What is the overall NVST consensus from analysts for Envista Holdings Corporation?
The overall analyst consensus for NVST is neutral. Out of 22 Wall Street analysts, 7 rate it as Buy, 8 as Hold, and 0 as Sell, with a median price target of $29.00.
How accurate are NVST stock price projections?
Stock price projections, including those for Envista Holdings Corporation, are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: April 21, 2026 10:45 PM UTC